Products

Browse our products

Want to know more?
Reach out to our team to know more about the product or how to purchase
 
Get more information

CorTechs.ai NeuroQuant® General

Clinicians rely on accurate and up to date information for the diagnosis of neurodegenerative diseases such as Alzheimer’s disease, epilepsy, multiple sclerosis, and brain trauma.

Until recently, clinicians have relied on the radiology report and the radiologist’s opinion with no way of accurately determining the extent of neurodegenerative diseases or ability to measure their progression over time. CorTechs.ai’s NeuroQuant® and LesionQuant™ address these issues.

Getz Healthcare has partnered with CorTechs.ai to bring these solutions to the Asia-Pacific region.

CorTechs.ai offers the most advanced artificial-intelligence-based methods for MR image analysis and delivers highly accurate and clinically relevant quantitative data for use in the diagnosis of brain diseases.

CorTechs.ai founder and co-creator of FreeSurfer, brain imaging software, Dr. Anders Dale, has created a culture of innovation with the purpose of improving the quality of patient care.

NeuroQuant®

NeuroQuant® is the first and most widely used clinical solution for brain MRI quantification in the world. Scans support many of the most prominent radiologists and neurologists with highly accurate brain segmentation and volumetric data.

CorTechs.ai NeuroQuant® is used to aid in the accurate diagnosis, and effective treatment options for neurodegenerative conditions such as Alzheimer’s disease, epilepsy, multiple sclerosis, and brain trauma. CorTechs.ai NeuroQuant® analyses and produces five reports that assesses neurological atrophy.

CorTechs.ai has developed a dynamic brain atlas using thousands of healthy MRI scans, which NeuroQuant® uses to compare and report neurological abnormalities in patients that are matched based on sex and aged between 3 to 100 years old.

LesionQuant™

CorTechs.ai LesionQuant™ FLAIR report provides volumetric and quantitative information on lesions and four brain structure volumes. CorTechs.ai LesionQuant™ aids physicians in monitoring the disease progression of multiple sclerosis and other neurodegenerative diseases, enabling them to be better prepared to assess and treat these conditions. 

CorTechs.ai LesionQuant™ is able to provide volumes and %ICV (Intracranial Volume) for all new and enlarging lesions and includes lesion burden calculations. LesionQuant™ can be used to conduct longitudinal evaluations, which provides the physician with information on how the lesions have changed over time and enables physicians to better evaluation treatment plans and options. 
 
Locations Where CorTechs.ai Products are Available in Australia

 

Related Products

    DISCLAIMER
    PROFESSIONAL CERTIFICATION. THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
    Getz Healthcare shares your commitment to achieving the best possible patient outcomes by connecting healthcare professionals with the finest medical technologies and supplies in the market.
    By continuing, you are acknowledging that you are a registered healthcare professional with a valid certification.

    No, I Disagree